Skip to content

Clinical trials

Completed Breast Neoplasms, Male trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms, Male Status: Completed Country / region: United States Clear all

175 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200011
200114
200210
20037
200413
200518
200618
200715
20089
20099
201013
20117
20123
20136
20143
20151
20161
20173
20183

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed175

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)45
University of Washington14
Alliance for Clinical Trials in Oncology12
Memorial Sloan Kettering Cancer Center8
Case Comprehensive Cancer Center6
City of Hope Medical Center4
H. Lee Moffitt Cancer Center and Research Institute4
Jonsson Comprehensive Cancer Center4
National Institutes of Health Clinical Center (CC)4
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms, Male175
Breast Neoplasms173
Carcinoma, Non-Small-Cell Lung27
Colonic Neoplasms24
Carcinoma, Ovarian Epithelial22
Prostatic Neoplasms21
Rectal Neoplasms21
Pancreatic Neoplasms17
Carcinoma, Renal Cell15
Salivary Gland Neoplasms15

Trials

Showing 1 to 25 of 175. Each trial links to its page on Pharma Observatory.

75 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.